Senin, 24 September 2018

MEDCHAIN


INTRODUCTION: the fundamental problems with medical information
For medical information to be useful, it must be accessed with ease, anywhere, anytime. However, today, medical records are inaccessible and regrettably dispersed. This makes it almost impossible for doctors, researchers, developers of treatments, decision makers and even patients to access these vital records at a time they are needed most. Of course, patients’ medical information is recorded in line with standard practice at hospitals. The problem is these medical records are dispersed in multiple EMRs, prescription records, specialist databases, etc. making it extremely difficult to access. Yes, the accessibility of medical information can mean the difference between life and death for a patient.
There is yet another problem: patients have no control over the privacy of their own medical information today! They do not know who accesses their own medical information. They do not know whether someone sells their medical information to researchers (and makes money from it, really). They hardly have any way of protecting these vital, sensitive pieces of information from predators – or even hackers.
There is yet another problem that rears its ugly head very often. Assuming a man travels to another city – or another country and takes ill suddenly, to the point that he is unable to speak, how on earth can doctors know his medical history and render the best help possible? How will doctors know his allergies, for instance? The ‘hows’are endless and providing answers to these questions and several others could save untold number of lives worldwide.
 Medchain – the medical blockchain that saves lives
Medchain is building a unique platform for patient’s medical data. It allows patients to store their own data offchain in an appropriate geographic domain, and give access to doctors and specialists anywhere regardless of the payer network or EMR used.
For the first time in human history, patients, doctors and hospitals can store data into a single platform, a compliant cloud which becomes part of the Medchain’s ecosystem. Patients can access their data at any time and allow other doctors and hospitals to have access to any part of the data the patient intends to share.
It is on record that over 8.5 million people die from cardiovascular disease, stroke and hypertension each year, deaths that could be avoided. Medchain hopes to prevent these deaths by implementing known, existing methods of cardiovascular screening in their platform.
MedChain believes that all personal data has value and should be in the control of the customer. The customer can decide if they want to sell it in an anonymized form, for example to insurers or pharma companies, but that is for them to decide. According to Seidenberg in Wired, 85 percent of smartphone buyers expect to access personal health data on their devices .
In Medchain platform, researchers and pharmaceutical companies can access the data in fully anonymised form. Based on cryptography and blockchain technology, there is enhanced transparency and reliability in medical data exchange at every level from devices to EMR to unprecedented opportunities for privatised big data sharing.
The global market size of medical data: a reason to be part of Medchain
The average cost of developing a new drug is $2.6 billion US taken over 106 samples and 10 companies. The annual development budget in the US is $153 billion dollars per year. Founder Mark Baker has firsthand experience in this sector doing big data analysis for a crucial part of the development of a highly successful drug as well as big data experience as CTO in a major predictive analytics player.
Ultimately, the potential medcal big data market is a substantial portion of the future drug development market. In addition, and acting as an enabler, Transparency Market Research’s study of the Electronic Health Records (EHR) Market values the global EHR market at $15.56 billion USD (Growing to $23.98 billion USD).
By creating a system to monetize data in the EHRs, Medchain hopes to bring extra value to the market – to the benefit of patients and doctors and the entire community.
      Medchain – a platform with immense social benefit
Community-based anonymized patient data has already produced advances against WHO top ten diseases such as obesity, diabetes, hypertension, and heart failure. Population data lets researchers tackle the big issues in medicine. By patients opting in and sharing their data, they promote the research breakthroughs that can one day improve their own health and help people who are suffering from similar health issues.
Companies that wish to harvest information for the production of a new drug, for instance, pay for the data and patients are paid for their contribution.
In summary, Medchain:
  1. Enables emergency access to medical data – something that can save untold lives.
  2. Enables patients to monetize their medical data.
  3. Enables people to access their own medical data anytime, anywhere.
  4. Enables people to have control over the privacy of their medical data.
  5. Enables individuals to purchase digitally transmitted medical services, such as diagnostic services from institutions participating in the system.
  6. Etc.
                   THE SALE OF VALUABLES (MedChain)
medchain.png
Token MedChain designed as a token compatible ERC20 on the platform of the Astraleum and use of blocking technology. The target group MedChain is an airline, a travel agency, a market leader, as well as online shops around the world. With benefits such as that, MedChain, based on blocking technology advanced, secure and effective, will master billions of dollars in the global marketplace.
kinds of problems the project solves?
Below are the problems identified. Increase the company's obligations: Points that are not used are considered liabilities. Because of the points, the customer is less and less used, the liabilities of the company to more significant and negative impact on the financial forecasts of you. The poor performance of the loyalty program: this is due to the low usage of the points that the company can not achieve, the performance of a loyal program, as expected. poor performance, like when you consider the social costs for the customer and the business
the complexity of the control points: average registered 29 program is different, so it is hard to control the points and leads to the fact that the points expire. Profits are from this platform. Both users and companies can use the platform MedChain. Users can redeem their points for MedChain tokens (MedChain) or use their points in the shop body. Users get access to promotion through advertising channels Access to advertising by companies that are interested.
MedChain Wallet allows you to simultaneously manage and integrate multiple partners at once. The company has access to more customers, allowing you to quickly sell your products on the pointer. Model exchange MedChain help companies to effectively reduce their obligations. Partners can encourage more loyalty to potential customers using feed appointments and saving MedChain
AUTHOR
Bitcointalk Username: Avansa
Diposting oleh di

Tidak ada komentar:

Posting Komentar

Langganan: Posting Komentar (Atom)